SNSS News and Press, Viracta Therapeutics Inc Com

Viracta Therapeutics Announces Closing of Merger with Sunesis Pharmaceuticals and $65M Private Placement Shares of Viracta to commence trading on the Nasdaq Global Select Market on February 25, 2021 under ticker symbol 'VIRX' Cash and cash equivalents of over $120 million as...

Sunesis Pharmaceuticals ([[SNSS]] +32.5%) is extending yesterday’s double-digit gain after announcing the company’s financial results for the year 2020.Per the 10-K submitted today, the company’s diluted net loss per share for Q4 2020 has dropped ~68.1% YoY to $0.15&...

Gainers: Sunesis Pharmaceuticals (SNSS) +38%, Owens & Minor (OMI) +32%, Salarius Pharmaceuticals (SLRX) +20%, Poseida Therapeutics (PSTX) +20%, PRA Health Sciences (PRAH) +19%.Losers: Rafael (RFL) -12%, Constellation Pharmaceuticals (CNST)...

R. R. Donnelley & Sons Company (RRD) +46% on Q4 results.Sypris Solutions (SYPR) +62%.Salarius Pharmaceuticals (SLRX) +21% after initiating expansion stage of phase 1/2 clinical trial of Seclidemstat.Arlo Technologies (ARLO) +26% on Q4 results.Globalstar, Inc. (GSAT) +25%.Re...

Gainers: Yunhong CTI (CTIB) +51%.TimkenSteel (TMST) +42%.Frank's International (FI) +33%.Sunesis Pharmaceuticals (SNSS) +22%.EverQuote (EVER) +14%.China Southern Airlines (ZNH) +14%.The L.S. Starrett (SCX) +14%.Centrais Eletricas Brasileiras (EBR) +11%.Ardagh Group (ARD) +11%.Vascul...

Gainers: Vascular Biogenics (VBLT) +22%, Sunesis Pharmaceuticals (SNSS) +21%, Savara (SVRA) +8%, Pandion Therapeutics (PAND) +5%.Losers: PAVmed (PAVM) -17%, Isoray (ISR) -16%, Vaccinex (VCNX) -16%, Onconova Therapeutics (ONTX) -15%, elect...

There’s Blood In The Streets, But Opportunity Could Be Presenting Itself With Penny Stocks What’s your strategy for finding the best penny stocks to buy ? At the top of my mind, there are a few things to look at. One of them is industry sentiment. Several industries ha...

Viracta Therapeutics Announces Notice of Allowance for U.S. Patent Application Covering the Use of its Combination Product Candidate for the Treatment of Epstein-Barr Virus-associated Lymphoma Resulting patent to extend Viracta's intellectual property protection into at least 20...

Viracta Therapeutics to Participate in Upcoming Virtual Investor Conferences PR Newswire SAN DIEGO , Feb. 11, 2021 /PRNewswire/ -- Viracta Therapeutics, Inc. (Viracta or the Company), a precision oncology company targeting virus-associated malignancies, today...

Biotech Penny Stocks For Your January Watch List Last week was a wild one for penny stocks and blue-chip stocks alike. While we saw more action in smaller companies, both the Russell 2000 Small-Cap ETF ( IWM ) and the S&P 500 ETF ( SPY ) pulled back. One of the b...